It is noteworthy that a lack of effect is consistent with work in men [55], but differs from the correlation among serum selenium, selenoprotein P, and glutathione peroxidase activity, three markers of selenium status, that have been reported to identify patients at high risk for poor prognosis at the time of breast cancer diagnosis [4]. This evidence concerns the gene SELENOP and breast cancer.